10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Most Viewed Portfolios

View All

Articles

Forget the Top Talk -- QE5 Is Coming, and Here's How to Profit

09.29.14 | 02:03 PM

BALTIMORE (Stockpickr) -- Selloff. Correction. Car crash. Whatever you want to call it, last week's 1.4% drop in the S&P 500 was ugly -- especial...

5 Hated Earnings Stocks You Should Love

09.29.14 | 01:42 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter